Trial Outcomes & Findings for Melatonin and Ulcerative Colitis: A Pilot Clinical Trial (NCT NCT00790478)
NCT ID: NCT00790478
Last Updated: 2021-02-12
Results Overview
Recruitment status
TERMINATED
Study phase
PHASE2
Target enrollment
3 participants
Primary outcome timeframe
April 2010
Results posted on
2021-02-12
Participant Flow
Study was terminated. No data were analyzed and data have since been destroyed.
Participant milestones
| Measure |
Melatonin
Melatonin
|
Placebo
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: April 2010Population: Study was terminated. No data were analyzed, and data have since been destroyed.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: April 2010Population: Study was terminated. No data were analyzed, and data have since been destroyed.
Study was terminated. No data were analyzed, and data have since been destroyed.
Outcome measures
Outcome data not reported
Adverse Events
Melatonin
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Placebo
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place